Follow up of Autoantibodies in Active Tuberculosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2007 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Information provided by:
Tel-Aviv Sourasky Medical Center Identifier:
First received: October 27, 2007
Last updated: October 29, 2007
Last verified: October 2007

We have previoulsy shown that patients with active Tuberculosis develop a wide array of autoantibodies including rheumatoid factor, anti-CCP, Antinuclear facyor and anti Sm antibodies. The purpose of this study is to evaluate whether the level of autoantibodies decrease after treatment aganist tuberculosis.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Follow up of Autoantibodies in Active Tuberculosis

Resource links provided by NLM:

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Primary Outcome Measures:
  • Follow up after levels of autoantibodies [ Time Frame: 1 year ]

Biospecimen Retention:   Samples Without DNA

Serum of patients

Estimated Enrollment: 50
Study Start Date: November 2007
Estimated Study Completion Date: November 2008
Patients with tuberculosis
Healthy controls


Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients diagnosed with active tuberculosis who are currently receiving anti tuberculosis drugs


Inclusion Criteria:

  • Active Tuberculosis treated

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its identifier: NCT00551226

Contact: Ori Elkayam, M.D 97236973668

Tel Aviv Medical Center Not yet recruiting
Tel Aviv, Israel, 64239
Contact: Ori Elkayam, M.D    97236973668   
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Principal Investigator: Ori Elkayam, M.D Tel Aviv Medical Center
  More Information

No publications provided Identifier: NCT00551226     History of Changes
Other Study ID Numbers: 314-07
Study First Received: October 27, 2007
Last Updated: October 29, 2007
Health Authority: Israel: Ministry of Health

Keywords provided by Tel-Aviv Sourasky Medical Center:
Patients with tuberculosis

Additional relevant MeSH terms:
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Immunologic Factors
Physiological Effects of Drugs
Pharmacologic Actions processed this record on April 16, 2014